These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15171324)

  • 1. Results of cisplatin, adriamycin and etoposide chemotherapy in patients with recurrent and metastatic endometrial cancer.
    Bilgin T; Ozan H; Kara HF
    Eur J Gynaecol Oncol; 2004; 25(3):379-80. PubMed ID: 15171324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II trial of doxorubicin, 5-fluorouracil, etoposide, and cisplatin in advanced or recurrent endometrial carcinoma.
    Pierga JY; Diéras V; Beuzeboc P; Dorval T; Palangié T; Jouve M; Scholl SM; Garcia-Giralt E; Pouillart P
    Gynecol Oncol; 1997 Aug; 66(2):246-9. PubMed ID: 9264570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of advanced or recurrent endometrial carcinoma with combination of etoposide, cisplatin, and 5-fluorouracil: a phase II study.
    Pierga JY; Dieras V; Paraiso D; Dorval T; Palangie T; Beuzeboc P; Jouve M; Scholl SM; Garcia-Giralt E; Pouillart P
    Gynecol Oncol; 1996 Jan; 60(1):59-63. PubMed ID: 8557229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility study of combination chemotherapy with paclitaxel, doxorubicin and cisplatin without prophylactic granulocyte colony-stimulating factor injection for intermediate-to-high risk or recurrent endometrial cancer.
    Nagao S; Nishikawa T; Hanaoka T; Kurosaki A; Iwasa N; Hasegawa K; Fujiwara K
    Jpn J Clin Oncol; 2014 Nov; 44(11):1040-4. PubMed ID: 25183770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin, adriamycin, etoposide, megestrol acetate versus melphalan, 5-fluorouracil, medroxyprogesterone acetate in the treatment of endometrial carcinoma.
    Cornelison TL; Baker TR; Piver MS; Driscoll DL
    Gynecol Oncol; 1995 Nov; 59(2):243-8. PubMed ID: 7590480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Filgrastim support during combination chemotherapy using cisplatin, doxorubicin, and cyclophosphamide to treat advanced or recurrent endometrial cancer: a clinical study and literature review.
    Hall DJ; Martin DA; Kincaid K
    Eur J Gynaecol Oncol; 2003; 24(6):481-9. PubMed ID: 14658586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II trial of cisplatin, etoposide, and 5-fluorouracil in advanced non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study (PB586).
    Kucuk O; Shevrin DH; Pandya KJ; Bonomi PD
    Am J Clin Oncol; 2000 Aug; 23(4):371-5. PubMed ID: 10955866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of outcomes in patients treated with multi-agent regiments of cisplatin, adriamycin, and VP-16 versus carboplatin and paclitaxel for advanced and recurrent endometrial cancer.
    Olawaiye AB; Godoy HE; Shahzad MM; Rauh-Hain JA; Lele SB; Odunsi K
    Eur J Gynaecol Oncol; 2012; 33(5):477-9. PubMed ID: 23185791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of cisplatin, epirubicin, and cyclophosphamide (PEC regimen) in advanced or recurrent endometrial cancer: a retrospective clinical study.
    Gadducci A; Romanini A; Cosio S; Fanucchi A; Tanganelli L; Ciampi B; Genazzani AR
    Anticancer Res; 1999; 19(3B):2253-6. PubMed ID: 10472339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in advanced/recurrent endometrial carcinoma.
    Long HJ; Langdon RM; Cha SS; Veeder MH; Pfeifle DM; Krook JE; Ebbert LP; Tschetter LK; Roshon SG
    Gynecol Oncol; 1995 Aug; 58(2):240-3. PubMed ID: 7622111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase III comparison of methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) vs. doxorubicin and cisplatin (AC) in women with advanced primary or recurrent metastatic carcinoma of the uterine endometrium.
    Long HJ; Nelimark RA; Podratz KC; Suman V; Keeney GL; Nikcevich DA; Kugler JW; Rowland KM; Kardinal CG; Wos EJ
    Gynecol Oncol; 2006 Mar; 100(3):501-5. PubMed ID: 16185755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of recurrent and metastatic endometrial carcinoma with cisplatin and doxorubicin.
    Deppe G; Malviya VK; Malone JM; Christensen CW; Saunders D
    Eur J Gynaecol Oncol; 1994; 15(4):263-6. PubMed ID: 7957332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilot study of cyclophosphamide-doxorubicin-vincristine-cisplatin-etoposide hybrid chemotherapy in small cell lung cancer.
    Ohnoshi T; Hiraki S; Ueoka H; Kiura K; Kamei H; Horiguchi T; Kodani T; Maeda T; Tabata M; Shibayama T
    Cancer; 1993 Sep; 72(5):1597-601. PubMed ID: 8394202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy in recurrent epithelial ovarian cancer (EOC): an analysis of prognostic factors.
    Shamsunder S; Kumar L; Gupta S; Kumar S; Bhatla N; Singh R; Kochupillai V
    J Obstet Gynaecol Res; 2000 Jun; 26(3):215-22. PubMed ID: 10932985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative adjuvant chemotherapy with cisplatin, cyclophosphamide, and anthracycline (doxorubicin, epirubicin, pirarubicin) for endometrial cancer.
    Yahata H; Hirakawa T; Fujita T; Ariyoshi K; Sonoda K; Amada S; Kobayashi H; Nakano H
    Int J Clin Oncol; 2004 Aug; 9(4):317-21. PubMed ID: 15375709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infusional fluorouracil, etoposide, and cisplatin (FEP) in advanced and relapsed gastric cancer.
    Sohn JH; Jeung HC; Shin HJ; Rha SY; Roh JK; Noh SH; Min JS; Kim BS; Jang WI; Chung HC
    Am J Clin Oncol; 2003 Apr; 26(2):203-9. PubMed ID: 12714898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensive chemotherapy with cisplatin, doxorubicin, cyclophosphamide, etoposide and granulocyte colony-stimulating factor for advanced thymoma or thymic cancer: preliminary results.
    Oshita F; Kasai T; Kurata T; Fukuda M; Yamamoto N; Ohe Y; Tamura T; Eguchi K; Shinkai T; Saijo N
    Jpn J Clin Oncol; 1995 Oct; 25(5):208-12. PubMed ID: 7474409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II study of etoposide, doxorubicin, and carboplatin in the treatment of advanced gastric cancer.
    Wang X; Pang L; Feng J
    Am J Clin Oncol; 2002 Feb; 25(1):71-5. PubMed ID: 11823701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circadian-timed combination doxorubicin-cisplatin chemotherapy for advanced endometrial carcinoma. A phase II study of the Gynecologic Oncology Group.
    Barrett RJ; Blessing JA; Homesley HD; Twiggs L; Webster KD
    Am J Clin Oncol; 1993 Dec; 16(6):494-6. PubMed ID: 8256764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II study of daily oral etoposide plus ifosfamide plus cisplatin for previously treated recurrent small-cell lung cancer: a Hoosier Oncology Group Trial.
    Faylona EA; Loehrer PJ; Ansari R; Sandler AB; Gonin R; Einhorn LH
    J Clin Oncol; 1995 May; 13(5):1209-14. PubMed ID: 7738623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.